Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Gynaecology
  4. Back
  5. Gynaecology guidelines
  6. Management of suspicious cervix in pregnancy, Gynaecology (1091)
Announcements and latest updates

Welcome to the Right Decision Service (RDS) newsletter for August 2024.

  1. Contingency planning for RDS outages

Following the recent RDS outages, Tactuum and the RDS team have been reviewing the learning from these incidents. We are committed to doing all we can to ensure a positive outcome by strengthening the RDS to make it fully robust and clinically resilient for the future.

We would like to invite you to a webinar on 26th September 3-4 pm on national and local contingency planning for future RDS outages.  Tactuum and the RDS team will speak about our business continuity plans and the national contingency arrangements we are putting in place. This will also be a space to share local contingency plans, ideas and existing good practice. We would also like to gather your views on who we should send communications to in the event of future outages.

I have sent a meeting request for this date to all editors – please accept or decline to indicate attendance, and please forward on to relevant contacts. You can also contact Olivia.graham@nhs.scot directly to register your interest in participating.

 

2.National  IV fluid prescribing  calculator

This UK CA marked calculator is now live at https://righdecisions.scot.nhs.uk/ivfluids  . It has been developed by a multiprofessional steering group of leads in IV fluids management, as part of the wider Modernising Patient Pathways Programme within the Centre for Sustainable Delivery.  It aims to address a known cause of clinical error in hospital settings, and we hope it will be especially useful to the new junior doctors who started in August.

Please do spread the word about this new calculator and get in touch with any questions.

 

  1. New toolkits

The following toolkits are now live;

  1. Updated guidance on current and future Medical Device Regulations

We have updated and simplified this guidance within our standard operating procedures. We have clarified the guidance on how to determine whether an RDS tool is a medical device, and have provided an interactive powerpoint slideset to steer you through the process.

 

  1. Guide to six stages of RDS toolkit development

We have developed a guide to support editors and toolkit leads through the process of scoping, designing, delivering, quality assuring and implementing a new RDS toolkit.  We hope this will help in project planning and in building shared understanding of responsibilities throughout the full development process.  The guide emphasises that the project does not end with launch of the new toolkit. Implementation, communication and evaluation are ongoing activities throughout the lifetime of the toolkit.

 

  1. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:
  • Thursday 5 September 1-2 pm
  • Wednesday 24 September 4-5 pm
  • Friday 27 September 12-1 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

7 Evaluation projects

Dr Stephen Biggart from NHS Lothian has kindly shared with us the results of a recent survey of use of the Edinburgh Royal Infirmary of Edinburgh Anaesthesia toolkit. This shows that the majority of consultants are using it weekly or monthly, mainly to access clinical protocols, with a secondary purpose being education and training purposes. They tend to find information by navigating by specialty rather than keyword searching, and had some useful recommendations for future development, such as access to quick reference guidance.

We’d really appreciate you sharing any other local evaluations of RDS in this way – it all helps to build the evidence base for impact.

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

 

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

Management of suspicious cervix in pregnancy, Gynaecology (1091)

Warning

Objectives

To define the management of women who are pregnant and are found to have a concerning cervical appearance during speculum examination

Scope

To be applied to women who are pregnant and are found to have an abnormality of their cervix.

Audience

All healthcare professionals in Greater Glasgow and Clyde including midwives, doctors and nurses involved in the care of pregnant women where a cervical abnormality has been identified.

Please report any inaccuracies or issues with this guideline using our online form

Within pregnancy, speculum examinations are generally performed after a patient present with symptoms such as abnormal vaginal discharge, vaginal bleeding, pre-term labour or rupture of membranes.

History

Before the examination consider the following which can be determined by history taking.

  • Is infection suspected?
  • Has the patient had any previous treatment to her cervix?
  • Is there a history of abnormal smears?
  • Has she been sexually active recently?
  • Does she have a cervical suture or vaginal pessary in place?
  • Is she using vaginal pessaries which may change her vaginal discharge e.g. vaginal progesterone?
  • Is there a history consistent with early labour including rupture of membranes?

If cervical screening history is uncertain and the patient is ≥25 years of age, the national Scottish Cervical Call Recall System database (SCCRS) may contain relevant information.

Opportunistic cervical smears should not be taken during pregnancy within the Obstetric Department.

Diagnosis

If concerns regarding cervical appearance, it is important to describe and document the size, number, consistency and origin of any cervical lesions, along with any contact bleeding.

If any concern over appearance of cervix at examination, confirmation should be made by the on call Consultant or senior trainee (ST6/7) in the first instance.

If a vaginal infection is suspected, high vaginal swabs should be taken and consideration of STI screen.  These may include Chlamydia/Gonorrhoea nucleic acid amplification tests (NAAT) vulvovaginal swab or lesion swab for PCR medium e.g. for herpes.

Patients presenting with vaginal bleeding should be managed in line with current guidelines for Antepartum Haemorrhage or Vaginal bleeding in <24 weeks. (see relevant guidelines for gestation)

Cervical appearance during pregnancy

The appearance of the cervix can change in normal pregnancy. Features can include an increase in cervical size, a bluish appearance due to increase vascularity.  These physiological changes may appear suspicious to an inexperienced clinician (2).

Most cervical abnormalities are benign and patients can be reassured and managed conservatively.  Some changes are described below.

  • Cervical ectopy – most common benign abnormality and may be associated with increased physiological discharge, no further investigation required.
  • Nabothian Follicles/Cysts – normal finding in women of childbearing age
  • Cervicitis/inflammation of the cervix – this can be acute or chronic and are most likely associated with Sexually Transmitted Infections (HSV, chlamydia, gonnorrhoea, trichomonas). Screening with appropriate swabs should be undertaken.
  • Condyloma (genital warts) - may be present in remainder of genital tract including vagina and vulva.

Cervical Polyp –They can be found in up to 4% of women, and are commonly asymptomatic.  However, in pregnancy they may present with vaginal bleeding or antepartum haemorrhage. They can be ectocervical, endocervical or endometrial in origin.

Risk of malignancy is low estimated at <0.1% in the pre-menopausal woman (3).  If there is clinical concern that the polyp may be atypical and/or previous unresolved abnormal cervical cytology, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted.  This should be an urgently dictated letter, which is sent to colposcopy via Scottish Care Information gateway (SCI-gateway) referral pathway by the transcribing secretary.

All patients with cervical polyps, irrespective of antenatal management should be reviewed in postnatally (obstetrics or general gynaecology) at 6-12 weeks. This should be highlighted via Alert tab in Badger, and referral made using a dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.

Suspicious cervical mass - cervical carcinoma is rare in pregnancy with estimated prevalence 1-10/10 000 pregnancies (2). 

If malignancy is suspected on clinical examination in a stable patient, then referral for review at colposcopy via USOC (Urgent Suspicion of Cancer) pathway should be submitted.  This should be an urgently dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.

Colposcopy

Referral to colposcopy should be made by senior trainee (ST6/7)/consultant by written referral including summary of pregnancy.  This should be an urgently dictated letter, which is sent to colposcopy via SCI-gateway referral pathway by the transcribing secretary.  It is useful to copy in the patient’s named Obstetrician and their own GP.

Referral should contain:

  • Patient’s named Obstetrician and contact details (may be useful to include their secretary as a contact point)
  • Presenting symptoms
  • Clinical findings indicating referral
  • Investigations undertaken e.g. swabs
  • Placental site
  • Any issues with pregnancy

Clinical assessment of the cervix will be undertaken and outcome of this examination will be shared with patient’s named consultant Obstetrician and referring clinician.

Unless the suspicion of malignancy is high at colposcopy, it is most likely that a conservative approach will be adopted.  Any further follow-up will be arranged by the colposcopist postnatally.

If a biopsy during pregnancy if felt to be warranted, this will generally be undertaken by an experienced colposcopist in a theatre setting after planning with the obstetric team. This is due to the associated increase in haemorrhage and complications.

Editorial Information

Last reviewed: 14/06/2023

Next review date: 31/05/2028

Author(s): Dr Victoria Flannigan, Consultant O&G, Dr Sandra Wong, Consultant O&G.

Approved By: Gynaecology Clinical Governance Group

Document Id: 1091

References
  1. Panayotidis, Costas & Cilly, Latika. (2013). Cervical Polypectomy during Pregnancy: The Gynaecological Perspective. J Genit Syst Disor. 2. 10.4172/2325-9728.1000108.
  2. China S, Sinha Y, Sinha D, Hillaby K. Management of gynaecological cancer in pregnancy.The Obstetrician & Gynaecologist2017;19:139–46. DOI: 10.1111/tog.1236
  3. Nelson AL, Papa RR, Ritchie JJ. Asymptomatic Cervical Polyps: Can We Just Let them Be? Women’s Health. March 2015:121-126. doi:10.2217/WHE.14.86